Conversely, there were no significant differences between the 2 groups with regards to sex, age, BMI, tumor size, number of tumors, hepatitis, portal hypertension, comorbidity, AFP and all other biochemical blood tests, type of hepatectomy, cirrhosis, intraoperative blood loss and transfusion, and postoperative complications. This evidence concerns the gene AFP and liver disorder.